Patents by Inventor Stephen Wright

Stephen Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10709674
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; Aicardi syndrome; CDKL5 and Dup15q in comparison to other seizure types. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: July 14, 2020
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Orrin Devinsky
  • Patent number: 10709671
    Abstract: The present invention relates to the use of cannabidiol (CBD) in the treatment of focal seizures. In one embodiment the patients suffering from focal seizures are children and young adults. CBD appears particularly effective in reducing focal seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; CDKL5; Neuronal ceroid lipofuscinoses (NCL); febrile infection related epilepsy syndrome (FIRES); Aicardi syndrome and brain abnormalities in comparison to other seizure types. Significantly CBD additionally is very effective in the reduction of a sub-type of focal seizures, focal seizures with impairment.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: July 14, 2020
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Orrin Devinsky
  • Patent number: 10686609
    Abstract: Systems and methods are disclosed for providing a chain of authenticated citations, from an original source document available online, through a chain of later documents and posts. Also disclosed are systems and methods of machine scoring of user posts based on metrics related to the expected veracity of cited sources, and the degree to which cited source material or verifiable online content may have been modified.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: June 16, 2020
    Inventors: Stephen B. Heppe, Kenan G. Heppe, Trevor Wright
  • Patent number: 10682810
    Abstract: In an example of a three-dimensional printing method, a polymeric build material is applied. A fusing agent is selectively applied on at least a portion of the polymeric build material. The fusing agent includes cesium tungsten oxide nanoparticles, a zwitterionic stabilizer, and an aqueous vehicle. The polymeric build material is exposed to electromagnetic radiation to fuse the portion of the polymeric build material in contact with the fusing agent to form a layer.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: June 16, 2020
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Stephen G. Rudisill, Vladek Kasperchik, Alexey S. Kabalnov, Shannon Reuben Woodruff, Thomas M. Sabo, Jake Wright, Hector Lebron, Vanessa Verzwyvelt, Morgan T. Schramm, Matthew A. Shepherd
  • Publication number: 20200179303
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: February 14, 2020
    Publication date: June 11, 2020
    Inventors: Geoffrey GUY, Stephen WRIGHT, Alice MEAD, Orrin DEVINSKY
  • Publication number: 20200172537
    Abstract: A compound having the structure: or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein variables are defined in the specification. Also provided are methods of treatment as Janus Kinase inhibitors and pharmaceutical compositions containing the compounds of the invention and combinations thereof with other therapeutic agents.
    Type: Application
    Filed: August 9, 2018
    Publication date: June 4, 2020
    Applicant: Pfizer Inc.
    Inventors: Brian Stephen Gerstenberger, Andrew Fensome, Dafydd Rhys Owen, Matthew Frank Brown, Matthew Merrill Hayward, Felix Vajdos, Li Huang Xing, Stephen Wayne Wright
  • Patent number: 10653641
    Abstract: This invention relates to the use of CBD to treat mental disorders.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: May 19, 2020
    Assignee: GW Pharma Limited
    Inventors: Philip Robson, Geoffrey Guy, Stephen Wright, Emma Cheetham, Dominic Schiller
  • Publication number: 20200146979
    Abstract: The invention provides gastric residence systems, or components of gastric residence system such as segments or elongate members of gastric residence systems, with release rate-modulating films and methods for making and using such systems. The release rate-modulating films provide good control over release of agents (such as therapeutic, diagnostic, or nutritional agents) present in the gastric residence system. The films also permit higher drug loading in the gastric residence systems and components of gastric residence systems while maintaining good control over release of agents. Some embodiments of the films can provide resistance against burst release of agent upon exposure to alcohol.
    Type: Application
    Filed: June 8, 2018
    Publication date: May 14, 2020
    Inventors: Rosemary KANASTY, Nupura BHISE, Stephen ZALE, Bennett CARTER, Jung Hoon YANG, Andrew BELLINGER, Susan LOW, James WRIGHT, David ALTREUTER, Colin GARDNER
  • Publication number: 20200138738
    Abstract: The present invention relates in the use of cannabidiol (CBD) in the treatment of Sturge Weber syndrome. CBD appears particularly effective in reducing all types of seizures and non-seizure symptoms in patients suffering with Surge Weber syndrome. Preferably the CBD used is in the form of a highly purified extract of cannabis such that the CBD is present at greater than 98% of the total extract (w/w) and the other components of the extract are characterised. In particular the cannabinoid tetrahydrocannabinol (THC) has been substantially removed, to a level of not more than 0.15% (w/w) and the propyl analogue of CBD, cannabidivarin, (CBDV) is present in amounts of up to 1%. Alternatively, the CBD may be a synthetically produced CBD.
    Type: Application
    Filed: January 8, 2020
    Publication date: May 7, 2020
    Inventors: Geoffrey GUY, Stephen WRIGHT, Alice MEAD, Anne COMI
  • Patent number: 10603288
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Grant
    Filed: April 9, 2018
    Date of Patent: March 31, 2020
    Assignee: GW Research Limited
    Inventors: Geoffrey Guy, Stephen Wright, Alice Mead, Orrin Devinsky
  • Publication number: 20200097385
    Abstract: A computer-implemented method includes identifying a bad fix to a software product, where the software product includes a plurality of parts, and where the bad fix presents an error into a first part. A plurality of fixes to the software product, including the bad fix, are representable by a dependency graph indicating dependencies among the plurality of fixes. The dependency graph is recursively traversed to identify a subset of fixes that are dependent on the bad fix, where each fix in the subset of fixes includes a respective set of parts, and to add a reference to a respective most recent version of each part of each fix in the subset of fixes to a parts datastore. A remedial part and each part referenced in the parts datastore are packaged into a remedial fix, where the remedial part includes a correction to the error in the first part.
    Type: Application
    Filed: September 25, 2018
    Publication date: March 26, 2020
    Inventors: Payal Mehta, STEPHEN EVANS, Ian M. Hodges, Stephen Hurst, Michael Vrakopoulos, Andrew Wright, Daniel Jeffrey
  • Publication number: 20200090916
    Abstract: An ion source with an insertable target holder for holding a solid dopant material is disclosed. The insertable target holder includes a pocket or cavity into which the solid dopant material is disposed. When the solid dopant material melts, it remains contained within the pocket, thus not damaging or degrading the arc chamber. Additionally, the target holder can be moved from one or more positions where the pocket is at least partially in the arc chamber to one or more positions where the pocket is entirely outside the arc chamber. In certain embodiments, a sleeve may be used to cover at least a portion of the open top of the pocket.
    Type: Application
    Filed: February 6, 2019
    Publication date: March 19, 2020
    Inventors: Shreyansh Patel, Graham Wright, Daniel Alvarado, Klaus Becker, Daniel R. Tieger, Stephen Krause
  • Patent number: 10583096
    Abstract: The present invention relates to the use of cannabidiol (CBD) in the treatment of Sturge Weber syndrome. CBD appears particularly effective in reducing all types of seizures and non-seizure symptoms in patients suffering with Sturge Weber syndrome. Preferably the CBD used is in the form of a highly purified extract of cannabis such that the CBD is present at greater than 98% of the total extract (w/w) and the other components of the extract are characterised. In particular the cannabinoid tetrahydrocannabinol (THC) has been substantially removed, to a level of not more than 0.15% (w/w) and the propyl analogue of CBD, cannabidivarin, (CBDV) is present in amounts of up to 1%. Alternatively, the CBD may be a synthetically produced CBD.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: March 10, 2020
    Assignee: GW RESEARCH LIMITED
    Inventors: Geoffrey Guy, Stephen Wright, Alice Mead, Anne Comi
  • Publication number: 20200069608
    Abstract: The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; Aicardi syndrome; CDKL5 and Dup15q in comparison to other seizure types. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).
    Type: Application
    Filed: November 8, 2019
    Publication date: March 5, 2020
    Inventors: Geoffrey Guy, Stephen Wright, Alice Mead, Orrin Devinsky
  • Publication number: 20200056838
    Abstract: A method of recycling liquefied natural gas (LNG) boil-off gas (BOG) in natural gas liquefaction plants can include: supplying a feed gas to a liquefaction subsystem; liquefying the feed gas to produce LNG and end-flash gas (EFG); compressing the EFG to compressed EFG; using the compressed EFG as fuel gas; storing the LNG in one or more LNG tanks; compressing LNG BOG from the one or more LNG tanks to produce compressed LNG BOG; and either (1) operating in a recycle mode by supplying at least a portion of the compressed LNG BOG to the feed gas via a bidirectional line, or (2) operating in a fuel mode by (a) supplying a portion of the feed gas to the fuel gas via the bidirectional line and (b) supplying the compressed LNG BOG to the fuel gas.
    Type: Application
    Filed: July 23, 2019
    Publication date: February 20, 2020
    Inventors: Brett L. Ryberg, Stephen Wright, Kenichi Tadano, Naoki Watanabe
  • Publication number: 20200056839
    Abstract: A method of operating, during an at least partial shutdown of a refrigerant distribution subsystem in a natural gas liquefaction facility, can include: draining down at least a portion of a mixed refrigerant in one or more components of the refrigerant distribution subsystem into a high-pressure holding tank of a drain down subsystem, wherein draining down to the high-pressure holding tank is achieved by pumping the mixed refrigerant from the refrigerant distribution subsystem to the high-pressure holding tank or backfilling the refrigerant distribution subsystem with a backfill gas; and optionally, transferring at least a portion of the mixed refrigerant into a low-pressure drum from the high-pressure holding tank.
    Type: Application
    Filed: July 23, 2019
    Publication date: February 20, 2020
    Inventors: Brett L. Ryberg, Stephen Wright, Kenichi Tadano, Naoki Watanabe
  • Publication number: 20200056807
    Abstract: Liquefied natural gas (LNG) boil off gas (BOG) and/or end flash gas (EFG) can be used to recondense refrigerant vent gas. For example, a method can include: passing LNG BOG through a first condensing heat exchanger and/or passing an EFG from liquefaction system through a second condensing heat exchanger; and condensing the refrigerant vent gas in the first and/or second condensing heat exchangers, wherein (when using the first condensing heat exchanger) the LNG BOG is the coolant in the first condensing heat exchanger and (when using the second condensing heat exchanger) the EFG is the coolant in the second condensing heat exchanger, and wherein (when using both condensing heat exchangers) the first and second condensing heat exchangers are in parallel and not in series.
    Type: Application
    Filed: July 23, 2019
    Publication date: February 20, 2020
    Inventors: Brett L. Ryberg, Stephen Wright, Kenichi Tadano, Naoki Watanabe
  • Publication number: 20200022925
    Abstract: The present invention relates to the use of a combination of two different cannabinoids in the treatment of leukaemia. The combination of CBD with THC appears to be particularly effective in reducing cell number in this disease. Preferably the cannabinoids are used in the form of an extract of cannabis such that many of the naturally occurring compounds are co-extracted with the THC or CBD. Alternatively, the cannabinoids are present in the form of a highly purified extract of cannabis, wherein the CBD or THC are present at greater than 98% of the total extract (w/w) and the other components of the extract are characterised. Alternatively, the CBD and THC may be synthetically produced. A specific ratio of CBD and THC such as 10:1 to 1:10 (CBD:THC) or more preferably between 2:1 to 1:2 (CBD:THC) may be used.
    Type: Application
    Filed: February 16, 2018
    Publication date: January 23, 2020
    Applicant: GW Research Limited
    Inventors: Stephen Wright, Wai Liu, Katherine Scott, Angus Dalgleish
  • Publication number: 20200025513
    Abstract: An ejector system for ejecting/separating a store, such as a weapon, from a launch platform includes a pair of spring assemblies that each include nested springs that are contained in a housing when the spring assemblies are in a compressed configuration. To separate the store from the aircraft the spring assemblies each move from the initial compressed configuration to an extended configuration, using the potential energy stored in the springs when compressed. The extension of the springs extends the springs mostly out of the spring assembly housings, extending telescoped sleeves of the spring assemblies. The extension of the spring assemblies provides a safe and steady way of separating the store from the launch platform, while having the advantages of being reusable, low cost and low weight, not producing any debris, and providing a softer push than may be produced by other separation mechanisms, such as the use of pyrotechnic devices.
    Type: Application
    Filed: December 12, 2018
    Publication date: January 23, 2020
    Inventors: Philip Wright, Jayson Kahle Bopp, Stephen A. Streib, Brian R. Kavalar
  • Publication number: 20200012486
    Abstract: A method and system for processing a plurality of unordered software patches for one or more computer readable software programs configured to be executed in a computer system. The unordered software patches are obtained. The unordered software patches include relationship information for defining a relationship the unordered software patches have with a second software patch. For each unordered software patch, the relationship information of the unordered software patch is analyzed to determine the relationship the unordered software patch has with the second software patch. An entry for each unordered software patch is stored in a relationship data store in the data processing system or computer system. The entry comprises dependency data representative of the determined relationship the unordered software patch has with the second software patch. The unordered software patches are ordered based on the dependency data in the relationship data store.
    Type: Application
    Filed: July 5, 2018
    Publication date: January 9, 2020
    Inventors: Ian M. Hodges, Michael Vrakopoulos, Payal Mehta, Stephen Evans, Stephen Hurst, Andrew Wright